Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than fifty new technology based ventures, over half of which have already become public companies. He formed the first Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 110 Life Sciences companies which have already developed hundreds of products to treat major underserved medical needs for millions of patients. Brook was President and a Director of the Western Association of Venture Capitalists. He is a currently a Board member of the University of California at San Francisco Medical Foundation, the New Schools Foundation, Stanford’s Bio-X Advisory Council and the Stanford Eye Council. In 2007, he was awarded the “UCSF Medal” as their honorary degree equivalent. In 2008, he was elected a Fellow of the American Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National Venture Capital Association. In May, 2010, he received an Honorary Ph.D. from Georgia Tech.
Session Abstract – PMWC 2019 Silicon Valley
Session Synopsis: Three visionary pioneers of personalized/precision medicine will discuss their views of the field at its inception, its current status and their assessment of where it will be in the next decade. The group includes Craig Venter, Brook Byers and Ralph Snyderman who respectively helped develop personalized/precision medicine through their leadership in genomics, venture capital investing and healthcare design and delivery. Ralph Snyderman will moderate this exciting and informative fireside chat.